BioGRID ORCS Featured Datasets
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision Next revision Both sides next revision | ||
|
orcs:featured_screens [2018/08/28 18:56] biogridadmin [2017 Datasets] |
orcs:featured_screens [2019/10/09 16:12] biogridadmin |
||
|---|---|---|---|
| Line 3: | Line 3: | ||
| =====BioGRID Featured Datasets===== | =====BioGRID Featured Datasets===== | ||
| + | |||
| + | ==== 2019 Datasets ==== | ||
| + | * **[[https://orcs.thebiogrid.org/Dataset/114|Behan FM et al.]]** - **Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens.** Nature. April 10, 2019. | ||
| + | |||
| + | ==== 2018 Datasets ==== | ||
| + | * **[[https://orcs.thebiogrid.org/Dataset/65|Pan D et al.]]** - **A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing.** Science. February 2, 2018. | ||
| + | |||
| ==== 2017 Datasets ==== | ==== 2017 Datasets ==== | ||
| * **[[https://orcs.thebiogrid.org/Dataset/41|Meyers RM et al.]]** - **Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells.** Nature Genetics. December 1, 2017. | * **[[https://orcs.thebiogrid.org/Dataset/41|Meyers RM et al.]]** - **Computational correction of copy number effect improves specificity of CRISPR-Cas9 essentiality screens in cancer cells.** Nature Genetics. December 1, 2017. | ||
| * **[[https://orcs.thebiogrid.org/Dataset/22|Bertomeu T et al.]]** - **A high resolution genome-wide CRISPR/Cas9 viability screen reveals structural features and contextual diversity of the human cell-essential proteome.** Molecular and Cellular Biology. October 16, 2017. | * **[[https://orcs.thebiogrid.org/Dataset/22|Bertomeu T et al.]]** - **A high resolution genome-wide CRISPR/Cas9 viability screen reveals structural features and contextual diversity of the human cell-essential proteome.** Molecular and Cellular Biology. October 16, 2017. | ||